References
- Stollberger C, Finsterer J. Unmet needs in the cardiologic and neurologic work-up of left ventricular hypertrabeculation/noncompaction. Expert Rev Cardiovasc Ther. 2016;14(10):1151–1160.
- Aras D, Tufekcioglu O, Ergun K, et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail. 2006;12(9):726–733.
- Aras D, Ozeke O, Cay S, et al. Arrhythmogenic noncompaction cardiomyopathy: ıs there an echocardiographic phenotypic overlap of two distinct cardiomyopathies? J Cardiovasc Ultrasound. 2015;23(3):186–190.
- Ritter M, Oechslin E, Sutsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997;72(1):26–31.
- Nguyen PK, Rhee JW, Wu JC. Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review. JAMA Cardiol. 2016;1(7):831–841.
- Oh H, Ito H, Sano S. Challenges to success in heart failure: cardiac cell therapies in patients with heart diseases. J Cardiol. 2016;68(5):361–367.
- Bassetti B, Capogrossi MC, Pompilio G. Power ıs nothing without control: the enduring search for the best cell in cardiac cell therapy at a crossroads. Circ Res. 2016;119(9):988–991.
- Chen CH, Sereti KI, Wu BM, et al. Translational aspects of cardiac cell therapy. J Cell Mol Med. 2015;19(8):1757–1772.
- Cambria E, Steiger J, Gunter J, et al. Cardiac regenerative medicine: the potential of a new generation of stem cells. Transfus Med Hemother. 2016;43(4):275–281.
- Burridge PW, Diecke S, Matsa E, et al. Modeling cardiovascular diseases with patient-specific human pluripotent stem cell-derived cardiomyocytes. Methods Mol Biol. 2016;1353:119–130.
- Liu L, Lei I, Wang Z. Improving cardiac reprogramming for heart regeneration. Curr Opin Organ Transplant. 2016;21:588–594. [ Epub ahead of print].
- Le T, Chong J. Cardiac progenitor cells for heart repair. Cell Death Discov. 2016;18(2):16052. DOI:10.1038/cddiscovery.2016.52